The beneficial effects of lymphocytapheresis for treatment of Nephrotic syndrome

Therapeutic Apheresis

Volumn 6, Issue 2, 2002, Pages 167-173

  Yokoyama, Hitoshi ^a   Shimizu, Miho ^a   Wada, Takashi ^a   Yoshimoto, Keiichi ^a   Iwata, Yasunori ^a   Shimizu, Kazuaki ^a   Sakai, Norihiko ^a   Furuichi, Kengo ^a   Hisada, Yukimasa ^a   Takakuwa, Hiroshi ^a   Kobayashi, Ken Ichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Immunosuppressant; Lymphocyte apheresis; Nephrotic syndrome; T cells

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOSPORIN A; LOW DENSITY LIPOPROTEIN; PROTEIN;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE URINE LEVEL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LEUKAPHERESIS; MALE; NEPHROTIC SYNDROME; PNEUMONIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSION; LEUKAPHERESIS; NEPHROTIC SYNDROME; PROTEINURIA; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 0036252174     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00351.x     Document Type: Article

References (22)

1. Cyclosporine in the treatment of idiopathic nephrosis
2. Primary focal segmental glomerulosclerosis
3. A glomerular permeability factor produced by human T cell hybridomas
4. A new method of measuring albumin permeability in isolated glomeruli
5. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis
6. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome
7. Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis
8. Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome
9. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis
10. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys
11. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
12. The nature of the glomerular injury in minimal change and focal sclerosing glomerulopathies
13. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome
14. Impaired lymphocyte and suppressor cell function in minimal change nephropathy, membranous nephropathy and focal glomerulosclerosis
15. Immunodynamics of minimal change nephrotic syndrome in adults T and B lymphocyte subsets and serum immunoglobulin levels
16. "The FSGS factor:" Enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma
17. Protein clearance and selectivity determinations in childhood nephrosis: A reappraisal
18. The short- and long-term outcomes of membranous nephropathy treated with intravenous immunoglobulin therapy
19. Lymphocytapheresis
20. Lymphocytapheresis to treat rapidly progressive glomerulonephritis: A randomised comparison with steroid-pulse treatment
21. Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritis
22. Recovery of T-lymphocytes for adoptive immunotherapy by lymphapheresis of HIV-infected patients without alterations of virological, immunological or clinical parameters